Cargando…
Mind the gap – Managing tuberculosis across the disease spectrum
We currently have a binomial approach to managing tuberculosis. Those with active disease, ideally confirmed microbiologically, are treated with a standard 6-month, multi-drug regimen and those with latent infection and no evidence of disease with shorter, one or two drug regimens. Clinicians freque...
Autores principales: | Esmail, Hanif, Macpherson, Liana, Coussens, Anna K., Houben, Rein M.G.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044004/ https://www.ncbi.nlm.nih.gov/pubmed/35339424 http://dx.doi.org/10.1016/j.ebiom.2022.103928 |
Ejemplares similares
-
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis
por: Horton, Katherine C., et al.
Publicado: (2023) -
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis
por: Gray, Adam Thorburn, et al.
Publicado: (2023) -
Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study
por: Richards, Alexandra S, et al.
Publicado: (2023) -
The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?
por: Seddon, James A., et al.
Publicado: (2018) -
Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology
por: Frascella, Beatrice, et al.
Publicado: (2020)